Pancreatic triacylglycerol distribution in type 2 diabetes. Reply to Hollingsworth K. G., Al Mrabeh A., Steven S. et al [letter]

被引：0
|
作者：
Paul Begovatz
Alessandra Bierwagen
Jesper Lundbom
Michael Roden
机构：
[1] Leibniz Center for Diabetes Research at Heinrich Heine University,Institute for Clinical Diabetology, German Diabetes Center
[2] Heinrich Heine University Düsseldorf,Department of Endocrinology and Diabetology, Medical Faculty
来源：
Diabetologia | 2015年 / 58卷
关键词：
Beta cell; Ectopic fat; Insulin sensitivity; Lipids; Magnetic resonance imaging; Pancreas; Pancreatic steatosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2679 / 2681
页数：2
相关论文
共 50 条
  • [1] Pancreatic triacylglycerol distribution in type 2 diabetes. Reply to Hollingsworth K. G., Al Mrabeh A., Steven S. et al [letter]
    Begovatz, Paul
    Bierwagen, Alessandra
    Lundbom, Jesper
    Roden, Michael
    DIABETOLOGIA, 2015, 58 (11) : 2679 - 2681
  • [2] Pancreatic duct hyperplasia/dysplasia in type 1 diabetes and pancreatic weight in individuals with and without diabetes. Reply to Kobayashi T, Aida K, Fukui T et al [letter] and Saisho Y [letter]
    Martha L. Campbell-Thompson
    Desmond A. Schatz
    John S. Kaddis
    Mark A. Atkinson
    Diabetologia, 2016, 59 : 870 - 872
  • [3] Pancreatic duct hyperplasia/dysplasia in type 1 diabetes and pancreatic weight in individuals with and without diabetes. Reply to Kobayashi T, Aida K, Fukui T et al [letter] and Saisho Y [letter]
    Campbell-Thompson, Martha L.
    Schatz, Desmond A.
    Kaddis, John S.
    Atkinson, Mark A.
    DIABETOLOGIA, 2016, 59 (04) : 870 - 872
  • [4] Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Reply to Lambert GW et al (letter)
    Krabbe, K. S.
    Nielsen, A. R.
    Krogh-Madsen, R.
    Plomgaard, P.
    Rasmussen, P.
    Erikstrup, C.
    Fischer, C. P.
    Lindegaard, B.
    Petersen, A. M. W.
    Taudorf, S.
    Secher, N. H.
    Pilegaard, H.
    Bruunsgaard, H.
    Pedersen, B. K.
    DIABETOLOGIA, 2007, 50 (09) : 2029 - 2030
  • [5] Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Reply to Lambert GW et al (letter)
    K. S. Krabbe
    A. R. Nielsen
    R. Krogh-Madsen
    P. Plomgaard
    P. Rasmussen
    C. Erikstrup
    C. P. Fischer
    B. Lindegaard
    A. M. W. Petersen
    S. Taudorf
    N. H. Secher
    H. Pilegaard
    H. Bruunsgaard
    B. K. Pedersen
    Diabetologia, 2007, 50 : 2029 - 2030
  • [6] Electrical atrial vulnerability and renal complications in type 2 diabetes. Reply to Montaigne D, Coisne A, Sosner P et al [letter]
    Zethelius, Bjorn
    Gudbjornsdottir, Soffia
    Eliasson, Bjorn
    Eeg-Olofsson, Katarina
    Svensson, Ann-Marie
    Cederholm, Jan
    DIABETOLOGIA, 2016, 59 (04) : 863 - 864
  • [7] Electrical atrial vulnerability and renal complications in type 2 diabetes. Reply to Montaigne D, Coisne A, Sosner P et al [letter]
    Björn Zethelius
    Soffia Gudbjörnsdottir
    Björn Eliasson
    Katarina Eeg-Olofsson
    Ann-Marie Svensson
    Jan Cederholm
    Diabetologia, 2016, 59 : 863 - 864
  • [8] Reply to S. Barni et al, K. R. Dearing et al, and N. Murray (vol 32, pg 483, 2014)
    Paz-Ares, Luis
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (08) : 833 - 833
  • [9] Increasing evidence of the benefits of a transition coordinator in type 1 diabetes. Reply to White M, O’Connell M, Steinbeck K et al. [letter]
    Danièle Pacaud
    Sonia Butalia
    Diabetologia, 2021, 64 : 2352 - 2353
  • [10] Reply to the letter by A. S. Ravi Kumar et al. regarding “Detectability of colorectal neoplasia with FDG-PET/CT”
    Tomoko Hirakawa
    Jun Kato
    Journal of Gastroenterology, 2012, 47 : 728 - 729
12345